Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Progression-free Survival
Interventions: DRUG: fulvestrant|DRUG: anastrozole|DRUG: exemestane
Sponsor: AstraZeneca